What Researchers Did
Researchers conducted a randomized, sham-controlled trial to evaluate the effects of 60 daily sessions of hyperbaric oxygen therapy (HBOT) versus sham on male veterans aged 25-60 with combat-associated posttraumatic stress disorder (CA-PTSD).
What They Found
Of 63 randomized veterans, 56 completed the study (28 per group). The hyperbaric oxygen therapy group showed a significant decrease in mean CAPS-5 total score, dropping from 42.57 at baseline to 25.8 post-treatment.
What This Means for Canadian Patients
If further research confirms these findings, hyperbaric oxygen therapy could offer a novel treatment option for Canadian veterans suffering from combat-associated posttraumatic stress disorder. This could potentially improve their quality of life and reduce the burden of PTSD symptoms, though accessibility and cost would need consideration.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants.
Study Limitations
A limitation is that the study population was restricted to male veterans aged 25-60 with combat-associated PTSD, potentially limiting generalizability to other populations.